Get the latest news on ObsEva stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on OBSEF performance

Latest ObsEva Stock News | OTC:OBSEF | Benzinga

ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

Comments

ObsEva Stock News

News

Latest ObsEva Stock News | OTC:OBSEF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga